A network meta-analysis (NMA) of efficacy of zanubrutinib versus fixed-duration acalabrutinib plus venetoclax in treatment-na飗e (TN) chronic lymphocytic leukemia (CLL)

No Thumbnail Available

All Authors

Shadman,Mazyar
Yang,Keri
Xu,Sheng
Williams,Rhys
Munir,Tahla

LTHT Author

Munir, Talha

LTHT Department

Oncology
Haematology

Non Medic

Publication Date

2025

Item Type

Article

Language

Subject

Subject Headings